Ifp Advisors, Inc Arcturus Therapeutics Holdings Inc. Transaction History

Ifp Advisors, Inc

0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$14.82 - $25.48 $0 - $0	0 New	0 $0
Q3 2021 Oct 06, 2021	SELL	$27.88 - $58.25 $16,477 - $34,425	-591 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$25.79 - $42.11 $10,367 - $16,928	402 Added 212.7%	591 $19,000
Q1 2021 Apr 30, 2021	BUY	$38.75 - $86.92 $891 - $1,999	23 Added 13.86%	189 $9,000
Q4 2020 Jan 25, 2021	BUY	$34.61 - $123.66 $207 - $741	6 Added 3.75%	166 $8,000
Q3 2020 Oct 29, 2020	BUY	$37.49 - $63.19 $5,998 - $10,110	160 New	160 $6,000

168

26M

163K

173K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $471M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.